✦ LIBER ✦

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

✍ Scribed by Adriano Paccagnella; Adolfo Favaretto; Alba Brandes; Cristina Ghiotto; Driano Fornasiero; Antonio Volpi; Giovanni Pappagallo; Giuliana Festi; Angiolo Cipriani; Orazio Vinante; Vanna Chiarion-Sileni; Mario V. Fiorentino

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 434 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900615)65:12<2631::aid-cncr2820651205>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, etoposide, and mitomycin in t

Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study

✍ Stephen Davis; Maurizio Tomato; Lucio Crino; Mari Antonetta Colozza; Kenneth Lub 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 1 views

A total of 39 patients with non-small cell carcinoma of the lung (NSCL) were treated with cisplatin, etoposide, and mitomycin. A major response rate (complete response + partial response) was seen in 15 patients (39%). Median survival for all patients was 340 days; median survival of the responding

Cisplatin and etoposide (VP-16) as a sin

Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer. A phase II trial

✍ Corrado Boni; Giorgio Cocconi; Giancarlo Bisagni; Guido Ceci; Giuseppe Peracchia 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB 👁 1 views

A Phase II study of paclitaxel-ifosfamid

A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

✍ Christos Kosmas; Nicolas B. Tsavaris; Aristidis Polyzos; Haralambos P. Kalofonos 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

A Phase II study of all-trans-retinoic a

A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma : An Eastern Cooperative Oncology Group study

✍ Gregory P. Kalemkerian; Michael Jiroutek; David S. Ettinger; John A. Dorighi; Da 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

A randomized Phase III trial of etoposid

A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma

✍ Fikri İçli; İsmail Çelik; Faruk Aykan; Aytuǧ Üner; Ahmet Demirkazik; Ahmet Özet; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with adv

Carboplatin, etoposide, and accelerated

Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma : A phase II study

✍ Branislav Jeremic; Yuta Shibamoto; Ljubisa Acimovic; Slobodan Milisavljevic 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

## Background: It is not clear how well elderly patients with limited small cell lung carcinoma tolerate intensive chemotherapy, and they have often been treated with palliative intent. as an alternative strategy, the authors designed and employed a short term combination regimen consisting of carb